Back to the directory
Persephone Biosciences
We are using the gut microbiome to end cancer.
- Founded
- 2017
- Status
- Active
- Stage
- Early
- Team size
- 6
- Location
- San Diego, CA, USA
- Category
- Biotech & Drug Discovery
- Sector
- Therapeutics
About Persephone Biosciences
Persephone Biome develops live biotherapeutic products to modulate the metabolism of gut microbes, for applications in disease prevention and cure. We take a unique engineering approach using systems and synthetic biology to understand the complexities of the microbiome.
AI-powered Drug DiscoveryCOVID-19
Clinical trials
6 registered trials with this company as lead sponsor, 2019 to 2025.
- Status
- Unknown (1), Completed (1), Recruiting (1), Terminated (1)
- Conditions
- Dysbiosis, Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal, Non-small Cell Lung Cancer, Colorectal Cancer
NCT05472688, NCT04291755, NCT04638751, NCT06746285, NCT06091813, NCT04770649
Source: ClinicalTrials.gov.
Securities filings
1 Form D filing on record, 2021.
Filed as Persephone Biosciences, Inc.
Source: SEC EDGAR. Form D reports an exempt offering; it does not confirm funds raised.
Company data compiled and maintained by Healthcare Discovery.
